Alveolar Ridge Deficiency

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Geistlich Pharma
Geistlich PharmaSwitzerland - Root
1 program
1
Xenograft and allograftPhase 41 trial
Active Trials
NCT06342973Completed15Est. Oct 2025

Trial Timeline

Clinical trial activity over time

2024
2025
2026
Geistlich PharmaXenograft and allograft

Clinical Trials (1)

Total enrollment: 15 patients across 1 trials

NCT06342973Geistlich PharmaXenograft and allograft

Horizontal Ridge Augmentation With Demineralized Bone Allograft Layered With Xenograft - a Prospective Clinical Study

Start: Mar 2024Est. completion: Oct 202515 patients
Phase 4Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space